CA2593272A1 - Aerosol formulation for inhalation containing an anticholinergic agent - Google Patents
Aerosol formulation for inhalation containing an anticholinergic agent Download PDFInfo
- Publication number
- CA2593272A1 CA2593272A1 CA002593272A CA2593272A CA2593272A1 CA 2593272 A1 CA2593272 A1 CA 2593272A1 CA 002593272 A CA002593272 A CA 002593272A CA 2593272 A CA2593272 A CA 2593272A CA 2593272 A1 CA2593272 A1 CA 2593272A1
- Authority
- CA
- Canada
- Prior art keywords
- acid
- pharmaceutical preparation
- ethanol
- pharmaceutical
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005001297A DE102005001297A1 (de) | 2005-01-12 | 2005-01-12 | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| DE102005001297.3 | 2005-01-12 | ||
| PCT/EP2006/050002 WO2006074970A1 (de) | 2005-01-12 | 2006-01-02 | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2593272A1 true CA2593272A1 (en) | 2006-07-20 |
Family
ID=36204353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002593272A Abandoned CA2593272A1 (en) | 2005-01-12 | 2006-01-02 | Aerosol formulation for inhalation containing an anticholinergic agent |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060153777A1 (enExample) |
| EP (1) | EP1838282A1 (enExample) |
| JP (1) | JP2008526917A (enExample) |
| CA (1) | CA2593272A1 (enExample) |
| DE (1) | DE102005001297A1 (enExample) |
| WO (1) | WO2006074970A1 (enExample) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4108393A1 (de) * | 1991-03-15 | 1992-09-17 | Boehringer Ingelheim Kg | Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln |
| US6790856B2 (en) * | 2002-01-31 | 2004-09-14 | Boehringer Ingelheim Pharma Kg | Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments |
| DE10203741A1 (de) * | 2002-01-31 | 2003-08-14 | Boehringer Ingelheim Pharma | Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel |
| EP1908468A1 (de) * | 2002-08-14 | 2008-04-09 | Boehringer Ingelheim Pharma GmbH & Co. KG | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
| DE102004038885A1 (de) * | 2004-08-10 | 2006-02-23 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
-
2005
- 2005-01-12 DE DE102005001297A patent/DE102005001297A1/de not_active Withdrawn
-
2006
- 2006-01-02 JP JP2007550779A patent/JP2008526917A/ja active Pending
- 2006-01-02 WO PCT/EP2006/050002 patent/WO2006074970A1/de not_active Ceased
- 2006-01-02 EP EP06700053A patent/EP1838282A1/de not_active Withdrawn
- 2006-01-02 CA CA002593272A patent/CA2593272A1/en not_active Abandoned
- 2006-01-04 US US11/326,226 patent/US20060153777A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008526917A (ja) | 2008-07-24 |
| EP1838282A1 (de) | 2007-10-03 |
| WO2006074970A1 (de) | 2006-07-20 |
| US20060153777A1 (en) | 2006-07-13 |
| DE102005001297A1 (de) | 2006-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2540174C (en) | Aerosol formulation for inhalation, containing an anticholinergic agent | |
| US7611694B2 (en) | Aerosol formulation for inhalation comprising an anticholinergic | |
| CA2495275C (en) | Aerosol formulation for inhalation comprising an anticholinergic agent | |
| US9238031B2 (en) | Propellant-free aerosol formulation for inhalation | |
| CA2652694A1 (en) | Aerosol formulation containing ipratropium bromide and salbutamol sulfate | |
| US20090075990A1 (en) | Aerosol Formulation for Inhalation Containing an Anticholinergic Agent | |
| US20090306065A1 (en) | Aerosol formulation for inhalation containing an anticholinergic agent | |
| US20060034775A1 (en) | Aerosol formulation for inhalation containing an anticholinergic | |
| US20090317337A1 (en) | Aerosol formulation for inhalation containing an anticholinergic agent | |
| US20090170839A1 (en) | Aerosol formulation for inhalation containing an anticholinergic agent | |
| US20090221626A1 (en) | Aerosol formulation for inhalation containing an anticholinergic agent | |
| AU2003222791B2 (en) | Aerosol formulation for inhalation comprising a tiotropium salt | |
| IL155538A (en) | Inhalative solution formulation containing a tiotropium salt | |
| US20060153777A1 (en) | Aerosol formulation for inhalation containing an anticholinergic | |
| NZ536282A (en) | Aerosol formulation for inhalation comprising a tiotropium salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |